|
Q3 FY2026
As of Sep 26, 2026
|
Q2 FY2026
As of Jun 27, 2026
|
Q1 FY2026
As of Mar 28, 2026
|
Q4 FY2025
As of Dec 27, 2025
|
Q3 FY2025
As of Sep 27, 2025
|
Q2 FY2025
As of Jun 28, 2025
|
Q1 FY2025
As of Mar 29, 2025
|
Q4 FY2024
As of Dec 28, 2024
|
Q3 FY2024
As of Sep 28, 2024
|
Q2 FY2024
As of Jun 29, 2024
|
Q1 FY2024
As of Mar 30, 2024
|
Q4 FY2023
As of Dec 30, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jul 1, 2023
|
Q1 FY2023
As of Apr 1, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 24, 2022
|
Q2 FY2022
As of Jun 25, 2022
|
Q1 FY2022
As of Mar 26, 2022
|
Q4 FY2021
As of Dec 25, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Trade accounts receivable, less allowance of $12,490 and $12,904 | ||||||||||||||||||||
| Other receivables, including advances to independent contractors, less allowance of $18,759 and $17,812 | ||||||||||||||||||||
| Trade accounts receivable, less allowance of $8,090 and $12,490 | ||||||||||||||||||||
| Other receivables, including advances to independent contractors, less allowance of $15,314 and $18,759 | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Operating property, less accumulated depreciation and amortization of $494,295 and $473,642 | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Cash overdraft | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Current maturities of long-term debt | ||||||||||||||||||||
| Insurance claims | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Contractor escrow | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, excluding current maturities | ||||||||||||||||||||
| Insurance claims | ||||||||||||||||||||
| Deferred income taxes and other noncurrent liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Common stock, $0.01 par value, authorized 160,000,000 shares, issued 68,636,098 and 68,590,708 shares | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Cost of 34,927,155 and 34,531,982 shares of common stock in treasury | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||||
Loading...
